Clinical Trials of Schizophrenia: Optimizing Patient Reported Outcomes and Performance Outcome Assessments, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will discuss the relevance of PRO and PerfO assessments for schizophrenia, the practical application of PRO and PerfO assessments and the value of eCOA platforms.

There is growing recognition from regulatory agencies that data reported directly from patients, without interpretation from clinicians and other people, provide critical information regarding quality of life, cognitive function, treatment benefits and satisfaction.

The majority of clinical outcome assessments (COAs) in schizophrenia trials are clinician reported outcome (ClinRO) assessments such as the PANSS and various forms of CGI and functional instruments which use information from clinical interviews with the patient and perhaps a caregiver. These COAs provide critical insights into clinical status, making use of the expertise and insight of psychiatrists and other healthcare professionals.

However, there is growing recognition from regulatory agencies that data reported directly from patients, without interpretation from clinicians and other people, provide critical information regarding quality of life, cognitive function, treatment benefits and satisfaction. Thus, supplementing these assessments with other COA types, including Patient Reported Outcome (PRO) assessments and Performance Outcome (PerfO) assessments, may add valuable outcomes to enable better decision making in clinical trials.

Join Chris Edgar, PhD, Chief Science Officer, Cogstate and Jenny Ly, PhD, Senior Clinical Science Advisor, ERT in a live webinar on Thursday, June 10, 2021 at 11am EDT (4pm BST/UK) to hear presenters discuss the use of PROs and PerfOs to measure meaningful aspects of health in schizophrenia. The integration of such measures into clinical trials, including the use of eCOA, will also be addressed.

For more information, or to register for this event, visit Clinical Trials of Schizophrenia: Optimizing Patient Reported Outcomes and Performance Outcome Assessments.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website